Comparison on therapeutic efficacy and prognosis evaluation of extended pterional approach operation with the traditional operation treatment for frontotemporal contrecoup craniocerebral injury / 中国基层医药

ABSTRACT

Objective To compare on therapeutic efficacy and prognosis evaluation of extended pterional approach operation with the traditional operation treatment for frontotemporal contrecoup craniocerebral injury , and provide the clinical basis for the treatment.Methods By retrospective study,112 patients with frontotemporal contrecoup craniocerebral injury were selected randomly .There was extended pterional approach operation group ( observation group,58 cases) and traditional operation treatment group (the control group,54 cases).We observed and evaluated indexes including of postoperative GOS grade assessment ,intracranial pressure measurement of 1,3,6 day preoperative and postoperative and the outcomes after operation of two groups .Results The plant survival rate of the observation group was 10.34%(6/58),lower than that of the control group 27.78%(15/54),the difference was significant (χ2 =4.58,P<0.05);The residual rate in the observation group was 29.31%(17/558),more than that of control group 16.67%(9/54),the difference was significant (χ2 =4.20,P<0.05);The severe brain edema of the observation group was 10.34%(6/58),lower than that of the control group 20.37%(11/54),the difference was significant (χ2 =4.78,P<0.05);Subdural effusion of the observation group was 12.07%(7/558),lower than that of the con-trol group 24.07%(13/54),the difference was significant(χ2 =3.96,P<0.05).The intracranial pressure of observa-tion group after 1 days and 3 days after operation were(302.18 ±17.33)mmH2O and (260.32 ±17.42)mmH2O,low-er than that of the control group was (371.24 ±18.40)mmH2O and (322.17 ±16.28)mmH2O,the difference was significant(t=7.53,5.39,all P<0.05).Conclusion Extended pterional approach could clean wound and hemato-ma fully,bleed thoroughly ,and be conducive to the protection of brain function .It is important for the clinical value to improve the quality of life of patients .